Skip to main content

Compare Stocks

Date Range: 

 The Cooper CompaniesLuxottica GroupSTAAR SurgicalNational VisionAlcon
SymbolNYSE:COOOTCMKTS:LUXTYNASDAQ:STAANASDAQ:EYENYSE:ALC
Price Information
Current Price$389.19$55.80$110.68$49.94$68.35
52 Week RangeBuyN/ABuyBuyHold
MarketRank™
Overall Score1.91.31.41.21.5
Analysis Score2.30.01.31.32.2
Community Score2.72.62.12.82.5
Dividend Score1.71.70.00.00.0
Ownership Score1.71.71.70.00.8
Earnings & Valuation Score1.30.61.91.91.9
Analyst Ratings
Consensus RecommendationBuyN/ABuyBuyBuy
Consensus Price Target$385.50N/A$78.40$51.00$74.22
% Upside from Price Target-0.95% downsideN/A-29.17% downside2.12% upside8.59% upside
Trade Information
Market Cap$19.13 billion$27.07 billion$5.19 billion$4.07 billion$33.37 billion
Beta0.820.271.091.770.6
Average Volume275,19514,259723,651735,521929,307
Sales & Book Value
Annual Revenue$2.43 billion$10.34 billion$150.18 million$1.72 billion$7.51 billion
Price / Sales7.872.6234.562.364.44
Cashflow$14.82 per share$3.57 per share$0.71 per share$1.89 per share$4.78 per share
Price / Cash26.2615.62154.9026.4914.31
Book Value$71.71 per share$13.74 per share$3.59 per share$9.81 per share$39.54 per share
Price / Book5.434.0630.835.091.73
Profitability
Net Income$238.40 million$1.17 billion$14.05 million$32.80 million$-656,000,000.00
EPS$9.64$2.29$0.46$0.78$1.89
Trailing P/E Ratio80.9124.37582.561,248.81N/A
Forward P/E Ratio27.58208.8372.3836.55
P/E Growth2.74N/AN/A20.674.68
Net Margins9.81%N/A5.73%0.32%-10.53%
Return on Equity (ROE)12.79%N/A8.99%4.97%2.80%
Return on Assets (ROA)7.20%N/A7.12%1.84%1.94%
Dividend
Annual Payout$0.06$0.91N/AN/AN/A
Dividend Yield0.02%1.63%N/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout Ratio0.62%39.74%N/AN/AN/A
Years of Consecutive Dividend Growth1 YearsN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.36%0.19%N/A0.75%0.21%
Current Ratio1.27%1.18%5.79%1.56%2.29%
Quick Ratio0.70%0.88%5.25%1.25%1.50%
Ownership Information
Institutional Ownership Percentage95.76%0.09%85.35%N/A46.52%
Insider Ownership Percentage1.40%75.00%3.90%2.60%1.52%
Miscellaneous
Employees12,00085,15057512,79223,000
Shares Outstanding49.15 million485.06 million46.90 million81.42 million488.20 million
Next Earnings Date6/3/2021 (Confirmed)N/A8/4/2021 (Estimated)8/5/2021 (Estimated)8/17/2021 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableNot Optionable
SourceHeadline
Alcon (ALC) Shares Cross Below 200 DMA - NasdaqAlcon (ALC) Shares Cross Below 200 DMA - Nasdaq
nasdaq.com - May 14 at 1:14 AM
Eye-care giant Alcon debuts a loaded ad campaign with Yahoo - Marketing InteractiveEye-care giant Alcon debuts a loaded ad campaign with Yahoo - Marketing Interactive
marketing-interactive.com - May 14 at 1:14 AM
Massive Growth of Diagnostic Ophthalmic Devices Market by 2027 | Alcon, CooperVision, Abbott, STAAR Surgical, CIBA Vision, Nidek, Bausch, Carl Zeiss, Johnson & Johnson, Topcon – Test & Measurement - Test & MeasurementMassive Growth of Diagnostic Ophthalmic Devices Market by 2027 | Alcon, CooperVision, Abbott, STAAR Surgical, CIBA Vision, Nidek, Bausch, Carl Zeiss, Johnson & Johnson, Topcon – Test & Measurement - Test & Measurement
testmeasurement.com.au - May 13 at 7:32 AM
Glaucoma Treatment Devices Market 2021 Precise Outlook – Essilor, Lumenis, Alcon, Johnson and Johnson Vision Care – The Shotcaller - The ShotcallerGlaucoma Treatment Devices Market 2021 Precise Outlook – Essilor, Lumenis, Alcon, Johnson and Johnson Vision Care – The Shotcaller - The Shotcaller
theshotcaller.net - May 13 at 7:32 AM
Alcon inks U.S. selling rights for BlephExs eyelid cleaning device - Mass DeviceAlcon inks U.S. selling rights for BlephEx's eyelid cleaning device - Mass Device
massdevice.com - May 12 at 9:02 PM
Oversold Conditions For Alcon (ALC) - NasdaqOversold Conditions For Alcon (ALC) - Nasdaq
nasdaq.com - May 12 at 4:01 PM
Custom LASIK Market to Witness Huge Growth by 2028 | Alcon Laboratories, Johnson & Johnson, Bausch & Lomb – The Manomet Current - The Manomet CurrentCustom LASIK Market to Witness Huge Growth by 2028 | Alcon Laboratories, Johnson & Johnson, Bausch & Lomb – The Manomet Current - The Manomet Current
manometcurrent.com - May 11 at 8:21 AM
China Ophthalmic Devices Market Growth and Technology Advancements 2021 to 2025| Alcon Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Hoya Corporation, Johnson & Johnson – The Shotcaller - The ShotcallerChina Ophthalmic Devices Market Growth and Technology Advancements 2021 to 2025| Alcon Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Hoya Corporation, Johnson & Johnson – The Shotcaller - The Shotcaller
theshotcaller.net - May 8 at 9:58 AM
Artificial Lens Market 2021 SWOT Analysis and Key Business Strategies by Leading Players – ALCON, AMO (Abbott), Bausch + Lomb, HOYA, CARL Zeiss, Ophtec – The Shotcaller - The ShotcallerArtificial Lens Market 2021 SWOT Analysis and Key Business Strategies by Leading Players – ALCON, AMO (Abbott), Bausch + Lomb, HOYA, CARL Zeiss, Ophtec – The Shotcaller - The Shotcaller
theshotcaller.net - May 8 at 9:58 AM
Global Eye Care Medical Devices Market 2021 Future Investments | Alcon, Bausch + Lomb, Carl Zeiss Meditec, Ziemer – The Manomet Current - The Manomet CurrentGlobal Eye Care Medical Devices Market 2021 Future Investments | Alcon, Bausch + Lomb, Carl Zeiss Meditec, Ziemer – The Manomet Current - The Manomet Current
manometcurrent.com - May 7 at 1:15 PM
Molokai man, 41, arrested for violating travel quarantine - Honolulu Star-AdvertiserMolokai man, 41, arrested for violating travel quarantine - Honolulu Star-Advertiser
staradvertiser.com - May 7 at 8:14 AM
Analysts Have Conflicting Sentiments on These Healthcare Companies: Crispr Therapeutics AG (CRSP), Alcon (ALC) and Karuna Therapeutics (KRTX) - Smarter AnalystAnalysts Have Conflicting Sentiments on These Healthcare Companies: Crispr Therapeutics AG (CRSP), Alcon (ALC) and Karuna Therapeutics (KRTX) - Smarter Analyst
smarteranalyst.com - May 7 at 3:14 AM
Citi Upgrades Alcon Inc. (ALC) to Neutral, Worst of Pandemic Appears to be in Rearview - StreetInsider.comCiti Upgrades Alcon Inc. (ALC) to Neutral, Worst of Pandemic Appears to be in Rearview - StreetInsider.com
streetinsider.com - May 6 at 5:13 PM
Molokai man arrested on Maui for violating quarantine orders - KITV HonoluluMolokai man arrested on Maui for violating quarantine orders - KITV Honolulu
kitv.com - May 6 at 5:13 PM
Alcon | 05/06/21 - KTNV Las VegasAlcon | 05/06/21 - KTNV Las Vegas
ktnv.com - May 6 at 5:13 PM
Weighing in on vaccine patent waivers, Alcon and Ultragenyx upgraded at Citi and more in analyst action - Seeking AlphaWeighing in on vaccine patent waivers, Alcon and Ultragenyx upgraded at Citi and more in analyst action - Seeking Alpha
seekingalpha.com - May 6 at 12:13 PM
Alcons Q1 Sales Boosted By Equipment, Implantables In Surgical Segment, FY21 Outlook In-Line With Expectations - BenzingaAlcon's Q1 Sales Boosted By Equipment, Implantables In Surgical Segment, FY21 Outlook In-Line With Expectations - Benzinga
benzinga.com - May 5 at 9:20 PM
Alcon On Track for Largest Percent Decrease In Over a Year -- Data Talk - Marketscreener.comAlcon On Track for Largest Percent Decrease In Over a Year -- Data Talk - Marketscreener.com
marketscreener.com - May 5 at 9:20 PM
Alcon Inc (ALC) Q1 2021 Earnings Call Transcript - Motley FoolAlcon Inc (ALC) Q1 2021 Earnings Call Transcript - Motley Fool
fool.com - May 5 at 9:20 PM
Alcon On Track for Largest Percent Decrease In Over a Year — Data Talk - Morningstar.comAlcon On Track for Largest Percent Decrease In Over a Year — Data Talk - Morningstar.com
morningstar.com - May 5 at 4:20 PM
Alcon first quarter results improve | Berks Regional News | wfmz.com - WFMZ AllentownAlcon first quarter results improve | Berks Regional News | wfmz.com - WFMZ Allentown
wfmz.com - May 5 at 4:20 PM
Alcon Inc (ALC) Q1 2021 Earnings Call TranscriptAlcon Inc (ALC) Q1 2021 Earnings Call Transcript
finance.yahoo.com - May 5 at 4:20 PM
Alcons Q1 Sales Boosted By Equipment, Implantables In Surgical Segment, FY21 Outlook In-Line With Expectations - Yahoo FinanceAlcon's Q1 Sales Boosted By Equipment, Implantables In Surgical Segment, FY21 Outlook In-Line With Expectations - Yahoo Finance
finance.yahoo.com - May 5 at 11:06 AM
Alcon (ALC) Tops Q1 EPS by 4c - StreetInsider.comAlcon (ALC) Tops Q1 EPS by 4c - StreetInsider.com
streetinsider.com - May 5 at 11:06 AM
Alcon AG (ALC) has fallen 5.27% Wednesday In Premarket Trading - InvestorsObserverAlcon AG (ALC) has fallen 5.27% Wednesday In Premarket Trading - InvestorsObserver
investorsobserver.com - May 5 at 11:06 AM
DateCompanyBrokerageAction
5/4/2021The Cooper CompaniesKeyCorpBoost Price Target
4/23/2021The Cooper CompaniesRedburn PartnersInitiated Coverage
3/11/2021The Cooper CompaniesRaymond JamesBoost Price Target
3/11/2021The Cooper CompaniesCitigroupBoost Price Target
3/11/2021The Cooper CompaniesRobert W. BairdBoost Price Target
3/11/2021The Cooper CompaniesJefferies Financial GroupBoost Price Target
2/11/2021The Cooper CompaniesPiper SandlerBoost Price Target
1/25/2021The Cooper CompaniesWells Fargo & CompanyBoost Price Target
12/4/2020The Cooper CompaniesCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price Target
12/4/2020The Cooper CompaniesSmith Barney CitigroupBoost Price Target
9/24/2020The Cooper CompaniesOppenheimerReiterated Rating
9/4/2020The Cooper CompaniesJPMorgan Chase & Co.Boost Price Target
11/21/2018Luxottica GroupHSBCDowngrade
10/29/2018Luxottica GroupRoyal Bank of CanadaUpgrade
5/12/2021STAAR SurgicalCanaccord GenuityBoost Price Target
2/8/2021STAAR SurgicalBTIG ResearchReiterated Rating
1/19/2021STAAR SurgicalBenchmarkDowngrade
10/26/2020STAAR SurgicalSidotiDowngrade
7/8/2020STAAR SurgicalStephensBoost Price Target
1/20/2021National VisionMorgan StanleyBoost Price Target
1/11/2021National VisionLoop CapitalDowngrade
11/18/2020National VisionBerenberg BankDowngrade
11/6/2020National VisionBarclaysBoost Price Target
5/8/2020National VisionUBS GroupLower Price Target
5/8/2020National VisionGuggenheimLower Price Target
3/31/2021AlconArgusBoost Price Target
3/29/2021AlconSociete GeneraleReiterated Rating
3/3/2021AlconCredit Suisse GroupBoost Price Target
11/12/2020AlconSVB LeerinkBoost Price Target
(Data available from 5/15/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.